Clinical Trials Browser

Interventional × Prostatic Neoplasms × spartalizumab × Clear all

Prostatic Neoplasms

NCT03860272 2025-02-06

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

GastrointestinalGenitourinaryGynecologicSarcomaThoracic

Fibrolamellar hepatocellular carcinoma, Carcinoma, Non-Small-Cell Lung, Hemangiosarcoma, Ovarian Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT01420965 2019-07-10

Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer

Phase 2 Terminated

7 enrolled 7 charts

Genitourinary

Prostatic Neoplasms

Clinical Trials

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer

Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer